Nutralife Biosciences, Inc

CIK 1563463 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nutralife Biosciences, Inc.

Recent SEC filings

FiledFormAccession number
Jan 2, 2026D0001563463-25-000006
Dec 4, 2024REVOKED9999999997-24-004496
Mar 31, 2023NT 10-K0001493152-23-010228
Feb 28, 20238-K0001493152-23-006286
Nov 21, 202210-Q0001493152-22-033121
Nov 14, 2022NT 10-Q0001493152-22-031701
Oct 12, 20228-K0001493152-22-028252
Aug 22, 202210-Q0001493152-22-023676
Aug 17, 20228-K0001493152-22-023309
Aug 15, 2022NT 10-Q0001493152-22-022985
May 23, 202210-Q0001493152-22-014754
May 16, 2022NT 10-Q0001493152-22-013744
Apr 11, 202210-K0001493152-22-009623
Mar 30, 2022NT 10-K0001493152-22-008177
Nov 15, 202110-Q0001493152-21-028406
Oct 12, 202110-Q/A0001493152-21-025188
Aug 16, 202110-Q0001493152-21-020001
Jul 16, 202110-Q0001493152-21-017022
Jun 24, 202110-K0001493152-21-015197
May 12, 202110-Q0001493152-21-011126
Apr 22, 202110-Q0001493152-21-009463
Apr 12, 202110-Q0001493152-21-008537
Mar 31, 2021NT 10-K0001493152-21-007314
Mar 19, 202110-K0001493152-21-006466
Dec 30, 2020D0001493152-20-024528